Guidance and quality standards Awaiting development

Skip to filters Skip to results

Showing 1 to 25 of 309

Type: GuidanceRemove Type: Guidance filter

Guidance and quality standards awaiting development
Title	Type
Phrenic nerve pacing for ventilator-dependent high cervical spinal cord injury	Interventional procedures guidance
Phrenic nerve pacing for congenital central hypoventilation syndrome	Interventional procedures guidance
Caval valve implantation for tricuspid regurgitation	Interventional procedures guidance
Single-step scaffold insertion for repairing symptomatic chondral knee defects	Interventional procedures guidance
Selpercatinib for treating advanced thyroid cancer with RET alterations (MA review of TA742) [ID6288]	Technology appraisal guidance
Endoscopic bipolar radiofrequency ablation for malignant biliary obstruction	Interventional procedures guidance
Unilateral MRI-guided focused ultrasound thalamotomy for moderate-to-severe tremor in Parkinson's disease	Interventional procedures guidance
MRI guided focused ultrasound subthalamotomy in parkinson's disease	Interventional procedures guidance
Transperineal laser ablation (TPLA) for treating lower urinary tract symptoms of benign prostatic hyperplasia using a ultra-micro invasive approach.	Interventional procedures guidance
Electrically stimulated intravesical therapy for Interstitial Cystitis	Interventional procedures guidance
Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis	Interventional procedures guidance
Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention	Interventional procedures guidance
Laparoscopic insertion of a non-active implant for gastro-oesophageal reflux disease	Interventional procedures guidance
Pulsed Field Ablation (PFA) for atrial fibrillation	Interventional procedures guidance
Targeted Muscle Reinnervation for refractory pain after limb amputation	Interventional procedures guidance
Masitinib with riluzole for treating amyotrophic lateral sclerosis TS ID 10728	Technology appraisal guidance
Pembrolizumab with neoadjuvant chemotherapy and adjuvant endocrine therapy for treating ER-positive, HER2-negative early breast cancer [ID3993]	Technology appraisal guidance
Bupivacaine–meloxicam for treating postoperative pain [ID2728]	Technology appraisal guidance
Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833]	Technology appraisal guidance
Baloxavir marboxil for treating influenza in people at high risk of complications [ID3794]	Technology appraisal guidance
Lisocabtagene maraleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma after 1 systemic treatment [ID3869]	Technology appraisal guidance
Nicardipine (Nicaplant) for aneurysmal subarachnoid haemorrhage patients undergoing aneurysm clipping TS ID 10593	Technology appraisal guidance
Liposomal cytarabine–daunorubicin for treating relapsed or refractory acute myeloid leukaemia in people aged 1 to 21 years [ID4017]	Technology appraisal guidance
Zamtocabtagene autoleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more therapies TS ID 10765	Technology appraisal guidance
REGN5458 for treating relapsed or refractory multiple myeloma TS ID 10443	Technology appraisal guidance

Results per page

10
25
50
All